Incidence of complications in patients of Plasmodium vivax malaria at a tertiary center in Northwest India


  • Amitesh Nagarwal Department of Medicine, SMS Medical College, Jaipur, Rajasthan, India
  • P. D. Meena Department of Medicine, SMS Medical College, Jaipur, Rajasthan, India



Complications, Malaria, Plasmodium vivax


Background: Malaria is a protozoal disease caused by infection with parasites of Plasmodium species, such as P. vivax, P. falciparum, P. malariae, P. ovale and P. knowlesi through female Anopheles mosquito. Plasmodium vivax alone causes 60 to 65% of infections in India. The main objective of the study was to observe various complications in the patients affected with P. vivax malaria and to analyse the clinical, hematological and biochemical profile of these patients.

Methods: A non-randomized prospective study was carried out on 170 patients with acute febrile illness admitted in the department of Medicine, SMS Hospital, Jaipur during period from October 2011 to September 2012 presented The infection was confirmed by detection of parasite (for P. vivax) in peripheral blood film by thick and thin slide methods and rapid diagnostic test (Optimal test).

Results: Male preponderance was seen in the study. Death was noted in 5 (3%) patients. Thrombocytopenia (85%) was the most common finding observed. Level of serum creatinine was more than 1.5 mg/dl in 34.7% patients. Thirty-one patients (18.23%) had severe anaemia (Hb <6 gm/dl). Severe hypoglycemia was observed in 19 patients (<40-60 mg/dl). Acute renal failure was common comorbidity observed in majority of the patients. Mean LDH value was significantly higher in patients with hepatitis and anemia.

Conclusions: The clinical pattern of P. vivax monoinfection has changed recently. Every patient of P. vivax malaria should be evaluated thoroughly for clinical or biochemical evidence of any complications and patients presenting with complications should managed as per guidelines of severe malaria.


Lal S, Sonal GS, Phukan PK. Status of malaria in India. J Ind Acad Clin Med. 2000;5(1):19-23.

Kumar A, Valecha N, Jain T, Dash AP. Burden of malaria in India: retrospective and prospective view. Am J tropic med hygie. 2007;77:69-78.

Kondrashin AV. Malaria in the WHO Southeast Asia region. Ind J malariol. 1992;29(3):129-60.

Estimation of Malaria Disease Burden in India: Report of an Informal Consultative Meeting New Delhi, India. Epidemol. 2007; 91-99.

Grimberg BT, Udomsangpetch R, Xainli J, McHenry A, Panichakul T, Sattabongkot J, et al. Plasmodium vivax invasion of human erythrocytes inhibited by antibodies directed against the Duffy binding protein. PLoS med. 2007;4(12):e337.

Indian Express. 2 lakh in India die of malaria annually: Lancet. Available at: Accessed on 2019.

WHO Stands By Its Malaria Death Estimates. Available at: Accessed on 2019.

Howard RJ, Haynes JD, McGinniss MH, Miller LH. Studies on the role of red blood cell glycoproteins as receptors for invasion by Plasmodium falciparum merozoites. Molecul biochem parasitol. 1982;6(5):303-15.

WHO: Regional office for SEA. Malaria: Disease burden in SEA region. Available at Accessed 2019.

Mordecai EA, Paaijmans KP, Johnson LR, Balzer C, Ben‐Horin T, de Moor E, et al. Optimal temperature for malaria transmission is dramatically lower than previously predicted. Ecol Letters. 2013;16(1):22-30.

Naha K, Dasari S, Prabhu M. Spectrum of complications associated with Plasmodium vivax infection in a tertiary hospital in South–Western India. Asian Pacific J Tropic Med. 2012;5(1):79-82.

Sarkar D, Ray S, Saha M, Chakraborty A, Talukdar A. Clinico-laboratory profile of severe Plasmodium vivax malaria in a tertiary care centre in Kolkata. Tropic Parasitol. 2013;3(1):53.

George P, Alexander LM. A study on the clinical profile of complicated plasmodium vivax mono–infections. Asian Pacific J Tropic Med. 2010;3(7):560-2.

Singh H, Parakh A, Basu S, Rath B. Plasmodium vivax malaria: is it actually benign? J Infect Publ Health. 2011;4(2):91-5.

Sharma A, Khanduri U. How benign is benign tertian malaria? J Vector Borne Dis. 2009;46(2):141.

Kochar DK, Das A, Kochar SK, Saxena V, Sirohi P, Garg S, et al. Severe Plasmodium vivax malaria: a report on serial cases from Bikaner in northwestern India. Am J Tropic Med Hygi. 2009;80(2):194-8.

Mohapatra MK, Padhiary KN, Mishra DP, Sethy G. Atypical manifestations of Plasmodium vivax malaria. Ind J Malariol. 2002;39:18-25.

Hazra BR, Chowdhury RS, Saha SK, Ghosh MB, Mazumder AK. Changing scenario of malaria: a study at Calcutta. Ind J Malariol. 1998;35(2):111-6.

Kochar DK, Saxena V, Singh N, Kochar SK, Kumar SV, Das A. Plasmodium vivax malaria. Emerg Infect Dis. 2005;11(1):132.

Douglas NM, Anstey NM, Buffet PA, Poespoprodjo JR, Yeo TW, White NJ, et al. The anaemia of Plasmodium vivax malaria. Malaria J. 2012;11(1):135.

Erez A, Shental O, Tchebiner JZ, Laufer-Perl M, Wasserman A, Sella T, et al. Diagnostic and prognostic value of very high serum lactate dehydrogenase in admitted medical patients. Isr Med Assoc J. 2014;16(7):439-43.

Nadkar MY, Huchche AM, Singh R, Pazare AR. Clinical profile of severe Plasmodium vivax malaria in a tertiary care centre in Mumbai from June 2010-January 2011. J Assoc Physici Ind. 2012;60:11-3.

Bhatia M, Zemans RL, Jeyaseelan S. Role of chemokines in the pathogenesis of acute lung injury. Am J Respirat Cell Molecul Biol. 2012;46(5):566-72.






Original Research Articles